CMV reactivation and reinfection
Keynote lectures
• 10.00 Pathophysiology of fetal brain infection / Stephane Chavanas (France)
• 10.30 Disease burden: PI and NPI maternal infection / Daniele Lilleri (Italy)
• 11.00 Oral presentations
Keynote lectures
• 12.00 Prenatal prognostic factors: US and beyond / Yves Ville (France)
• 12.30 Prognostic amniotic fluid biomarkers of congenital CMV severity / Dana Wolf (Israel)
• 13.00 Oral presentations
, Wolf Dana
Keynote lectures
• 14.30 Diagnosis of maternal infection / Tizianna Lazzarotto (Italy)
• 15.00 Antiviral treatment in pregnancy / Marianne Leruez-Ville (France)
15.30 Oral presentations
, Leruez-Ville Marianne
Keynote lectures
• 17.45 Primary prevention by maternal education / Chrissie Jones (United Kingdom)
• 18.15 CMV vaccines: an overview / Mark Schleiss (United States of America)
• 18.45 Oral presentations
, Schleiss Mark
Keynote lectures
• 09.00 cCMVnet: The importance of a European Registry / Hermione Lyall (United Kingdom)
• 09.20 Development of a prognostic score / Daniel Blazquez-Gamero (Spain)
• 09.40 Neonatal MRI as a prognostic tool / Kachramanoglou Carolina (United Kingdom)
• 10.00 Oral presentations
, Blázquez-Gamero Daniel
, Kachramanoglou Carolina
Keynote lectures
• 11.15 Treatment of neonates and children: an overview / David Kimberlin (United States of America)
• 11.45 Neonatal screening: translation of research to policy / Mark Schleiss (United States of America)
• 12.15 Oral presentations
Keynote lectures
• 13.45 cCMV immunology update / Laura Gibson (United States of America)
• 14.05 Long term hearing loss / Ina Foulon (Belgium)
• 14.25 Vestibular and Olfactory nerve dysfunction / Natacha Teissier (France)
• 14.45 Oral presentations
